New drug combo aims to slow ALS in landmark trial

NCT ID NCT07161999

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial is testing an investigational drug called COYA 302 in 120 adults with ALS. The drug combines two immune-modulating agents to reduce inflammation that may damage nerves. Participants will receive either COYA 302 or a placebo for 24 weeks, with an option to continue on the active drug for another 24 weeks. The study measures changes in muscle function, breathing, and nerve damage markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
COYA 302 (low-dose interleukin-2 and abatacept biosimilar)
What this could lead to
If successful, this could lead to a treatment that slows the progression of ALS, helping people maintain function and independence longer.
What could go wrong
This is an early Phase 2 trial with only 120 participants, so results may not apply to everyone. The treatment may not slow the disease or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Austin Neuromuscular Center; National Neuromuscular Research Institute, PLLC

    RECRUITING

    Austin, Texas, 78759, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Barrow Neurological Institute

    RECRUITING

    Phoenix, Arizona, 85013, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • California Pacific Medical Center

    RECRUITING

    San Francisco, California, 94110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Cedars-Sinai Medical Center

    RECRUITING

    Los Angeles, California, 90048, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Columbia University Medical Center ALS Center

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory University

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hopital Neurologique de Montreal

    RECRUITING

    Montreal, Quebec, H3A 2B4, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Houston Methodist Stanley H. Appel Department of Neurology

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • London Health Sciences Center

    RECRUITING

    London, Ontario, N6A 3K7, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Massachusetts General Hospital

    RECRUITING

    Boston, Massachusetts, 02114, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Neurology Associates, P.C. Somnos Clinical Research

    RECRUITING

    Lincoln, Nebraska, 68510, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Northwestern

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Nova Southeastern University

    RECRUITING

    Davie, Florida, 33314, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Temple Neurology

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

    Contact Email: •••••@•••••

  • Texas Neurology, PA

    RECRUITING

    Dallas, Texas, 75206, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The University of Texas Health Science Center

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Thomas Jefferson University-Weinberg ALS Center

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Of Miami

    RECRUITING

    Miami, Florida, 33136, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of British Columbia

    RECRUITING

    Vancouver, British Columbia, V6T1Z3, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Florida Clinical and Translational Research Center

    RECRUITING

    Gainesville, Florida, 32610, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of South Florida

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Toronto/Sunnybrook Health Sciences Center

    RECRUITING

    Toronto, Ontario, M5S 3H2, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Washington University

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.